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Background: Donepezil, a reversible acetylcholinesterase inhibitor, improves cognitive function of patients with Alzheimer’s disease. It is reported 
that stimulation of vagus nerve attenuates inflammatory response. We sought to determine whether pharmacological stimulation of cholinergic 
system by donepezil affects atherogenesis and angiogenesis.
Methods: Apolipoprotein E-knockout mice (ApoE KO) were fed a high-fat diet and received infusion of angiotensin II for 4 weeks. A hind limb 
ischemia model was created by ligation of unilateral femoral artery. Donepezil was orally administered and physostigmine was administered through 
an osmotic minipump.
Results: (1) Donepezil as well as physostigmine, another acetylcholinesterase inhibitor, significantly reduced Oil Red O-positive area in the aorta of 
ApoE KO. Administration of donepezil suppressed expression of MCP-1 and TNF-_, and production of reactive oxygen species in the aorta.
(2) Blood flow recovery (laser Doppler imaging) and capillary density (PECAM-1 positive cells) in the ischemic hind limb were significantly attenuated 
in donepezil- as well as physostigmine-treated mice compared with control mice after 2 weeks. Donepezil reduced expression of IL-1` and vascular 
endothelial growth factor (VEGF) in the ischemic limb. Intramuscular injection of IL-1`to the ischemic limb reversed anti-angiogeic effect and 
VEGF down-regulation by donepezil. Hypoxia (1%O2) induced IL-1` expression in C2C12 myoblast cells, which was inhibited by preincubation with 
acetylcholine and LY294002, a phosphatidylinositol-3 kinase (PI3K) inhibitor. Donepezil inhibited phosphorylation of Akt, a downstream kinase 
of PI3K, in the ischemic limb, suggesting that acetylcholine suppresses PI3K/Akt pathway resulting in the suppression of IL-1 induction, thereby 
inhibits VEGF expression and angiogenesis.
Conclusions: The present study revealed that pharmacological stimulation of cholinergic system attenuates atherogenesis and angiogenesis 
through an anti-inflammatory effect. Acetylcholinesterase inhibitors may be useful for the treatment of atherosclerotic cardiovascular diseases.
